Polymyalgia rheumatica: clinical features and diagnostics

Abstract

Current data on epidemiology, pathomorphology, clinical manifestations and diagnosis of polymyalgia rheumatica is presented. Polymyalgia rheumatica occurs only in persons over 50 years of age. The etiological factors of the disease remain unknown. The pathomorphology of the disease is characterized by the absence of polyorganity and morphological changes in the study of biopsies of diseased muscles, inflammation of predominantly extraarticular synovial structures. The pain in the muscles has a constant, usually aching character, sharply increased during movement and persists at night. The intensity of pain depends on the activity of the disease. The use of non-steroidal anti-inflammatory drugs has no significant effect on the intensity of myalgia. Often, a few weeks after the onset of the disease, seronegative arthritis appears. Synovitis is characterized by a benign course, absence of erosive changes in the joint and joint deformities. Symptoms of the disease grow gradually, reaching a maximum severity within a month. Characteristic is the appearance of anorexia and depression, weight loss, it is possible to attach subfebrile or febrile fever. In some patients there are signs of inflammation of the vessels in the form of subclinical, weakly expressed vasculitis or giant cell arteritis with lesions of the extracranial branches of the carotid arteries and signs of vascular insufficiency in the blood supplying organs. Specific laboratory criteria for polymyalgia rheumatica do not exist. Diagnosis of the disease is based on the analysis of a number of clinical, laboratory and instrumental features, united by experts of the European League against rheumatism and the American College of Rheumatology in the form of diagnostic criteria for rheumatic polymyalgia. The disease has a polymorphic clinical picture and similarity of symptoms with inflammatory diseases of the joints, as well as with myopathies against a background of various pathologies of internal organs and systems. Despite the presence of diagnostic criteria, the diagnosis is established after the exclusion of diseases with similar clinical manifestations. Recognition of polymyalgia rheumaticа is often associated with a large volume of research, which makes the disease difficult in a differential diagnostic plan and contributes to an increase in the duration of the verification period of the diagnosis.

Keywords

polymyalgia rheumatica / classification criteria of polymyalgia rheumaticа / clinical manifestations of polymyalgia rheumaticа / seronegative arthritis / polyorganity / biopsy of painful muscles / systemic inflammation

References

[1] Бекетова, Т.В. Международные рекомендации по ведению больных гигантоклеточным артериитом и ревматической полимиалгией: итоги 2015 года / Т.В. Бекетова, А.М. Сатыбалдыев, Л.Н. Денисов // Научно-практическая ревматология. – 2016. – Т. 54, № 4. – С. 390–394.

[2] Бунчук, Н.В. Ревматические заболевания пожилых / Н.В. Бунчук. – М.: МЕДпресс-информ, 2010. – 270 с.

[3] Ватутин, Н.Т. Обзор рекомендаций по лечению ревматической полимиалгии (EULAR/ACR 2015) / Н.Т. Ватутин [и др.] // Архивъ внутренней медицины. – 2016. – № 1 (27). – С. 3–5.

[4] Лазебник, Л.Б. Трудности диагностики ревматической полимиалгии у больной с хроническим гастродуоденитом / Л.Б. Лазебник [и др.] // Эксперимент. и клин. гастроэнтеролог. – 2014. – № 6. – С. 85–89.

[5] Овчаренко, С.И. Сложности диагностики ревматической полимиалгии / С.И. Овчаренко [и др.] // Трудный пациент. – 2010. – № 6. – С. 23–26.

[6] Овчаренко, С.И. Ревматическая полимиалгия: сложности диагностики / С.И. Овчаренко, И.С. Щедрина, М.П. Троицкая // Лечащий врач. – 2011. – № 4. – С. 33–37.

[7] Олюнин, Ю.А. Ревматическая полимиалгия / Ю.А. Олюнин // Consilium Medicum. – 2013. – № 9. – С. 53–57.

[8] Оттева, Э.Н. Ревматическая полимиалгия: от эпидемиологии до перспектив лечения. / Э.Н. Оттева, А.Б. Островский // Практ. мед. – 2015. – Т. 2, № 3. – С. 88–93.

[9] Ревматология: национальное руководство / под ред. Е. Л. Насонова, В. А. Насоновой. – М.: ГЭОТАР-Медиа, 2008. – 720 с.

[10] Терещенко, И. В. Ревматичекая полимиалгия и гигантоклеточный височный артериит / И.В. Терещенко // Клин. мед. – 2005. – № 8. – С. 25–30.

[11] Barber, H.S. Myalgic syndrome with constitutional effects. Polymyalgia rheumatic / H.S. Barber // Ann. Rheum. Dis. – 1957. – № 16. – Р. 230–235.

[12] Bird, H.А. European diagnostic criteria for polymyalgia rheumatica / H.A. Bird // Ann. Rheum. Dis. – 2001. – Vol. 60. – Р. 1060–1063.

[13] Bird, H.A. European collaborating PMR group. A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumaticа / H.A. Bird [et al.] // Ann. Rheum. Dis. – 2005. – Vol. 64. – P. 626–629.

[14] Brian, F. Mandell. Polymyalgia rheumatica: Clinical presentation is key to diagnosis and treatment / F. Brian // Cleveland Clin. J. Med. – 2004. – Vol. 71, № 6. – Р. 489.

[15] Bruce, W., Senile Rheumatic Gout / W. Bruce // Br. Med. J. – 1888. – Vol. 2. (1450) – P. 811–813.

[16] Cantini, F. Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study / F. Cantini [et al.] // J. Rheumatol. – 2001. – Vol. 28. – Р. 1049–1055.

[17] Cantini, F. Inflammatory changes of hip synovial structures in polymyalgia rheumatic / F. Cantini [et al.] // Clin. Exp. Rheum. – 2005. – Vol. 23. – P. 462–468.

[18] Dasgupta, B. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism / American College of Rheumatology collaboration initiative / B. Dasgupta [et al.] // Ann. Rheum. Dis. – 2012. – Vol. 71. – Р. 484–492.

[19] Dejaco, C. 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism / American College of Rheumatology collaborative initiative / С. Dejaco [et al.] // Ann. Rheum. Dis. – 2015. – Vol. 74. – P. 1799–1807.

[20] Duhaut, P. Giant cell arteritis and polymyalgia rheumatica: role of viral infections / P. Duhaut, S. Bosshard, C. Dumontet // Clin. Exp. Rheumatol. – 2000. – Vol. 18, Suppl. 20. – P. 22–23.

[21] Evans, J.M. Polymyalgia rheumatica and giant cell arteritis / J.M. Evans, G.G. Hunder // Rheum. Dis. Clin. North Am. – 2000. – Vol. 26. – Р. 493–515.

[22] Gonzalez-Gay, M.A. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relaps in 10 year study // M.A. Gonzalez-Gay, C. Garcia-Porrua, M. Vazquez-Caruncho J. // Rheumatol. – 1999. – Vol. 26. – Р. 1326–1332.

[23] Gonzalez-Gay, M.A. Epidemiology of giant cell arteritis and polymyalgia rheumatica / M.A. Gonzalez-Gay [et al.] // Arthritis Rheum. – 2009. – Vol. 61. – Р. 1454–1461.

[24] Gran, J.T. The incidence of polymyalgia rheumatic and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987– 1994 // J.T. Gran, G.J. Myklebust // Rheumatol. – 1997. – Vol. 24. – Р. 1739–1743.

[25] Jones, J.G. ESR in polymyalgia rheumatica and giant cell arteritis (Letter) / J.G Jones, B.L. Hazleman // Ann Rheum. Dis. – 1983. – Vol. 42. – Р. 702–703.

[26] Pamuk, O.N. Giant cell arteritis and polymyalgia rheumatica innorthwestern Turkey: Clinical features and epidemiological data / O.N. Pamuk [et al.] Clin. Exp. Rheumatol. – 2009. – Vol. 27. – Р. 830–833.

[27] Roche, N.E. Correlation of interleukin-6 production and disease activity in Polymyalgia rheumatica and giant cell arteritis / N.E. Roche [et al.] // Arthritis Rheum. – 1993. – Vol. 36. – Р. 1286–1294.

[28] Salvarani, C. Cervical interspinous bursitis in active polymyalgia rheumatic / C. Salvarani [et al.] // Ann. Rheum. Dis. – 2008. – Vol. 67. – Р. 758–761.

[29] Salvarani, C. Polymyalgia rheumatica and giant-cell arteritis / C. Salvarani [et al.] // N. Engl. J. Med. – 2002. – Vol. 347. – Р. 261–271.

[30] Salvarini, C. Polymyalgia rheumatica: a disorder of extraarticular synovial structures? / C. Salvarani [et al.] // J. Rheumatol. – 1999. – Vol. 26. – Р. 518–521.

[31] Salvarani, C. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study / C. Salvarani, G.G. Hunder // Arthritis Rheum. – 2001. – Vol. 45. – Р. 140–145.

[32] Salvarani, C. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy / C. Salvarani [et al.] // Arthritis Rheum. – 1991. – Vol. 34. – Р. 351–356.

[33] Salvarani, C. Polymyalgia rheumatica / C. Salvarani, L. Macchioni, L. Boiardi // Lancet. – 1997. – Vol. 350. – Р. 43–47.

[34] Salvarani, C. Polymyalgia rheumatica / C. Salvarani, L. Macchioni, L. Boiardi // Lancet. – 2008. – Vol. 372. – Р. 234–245.

[35] Smeeth, L. Incidence of polymyalgia rheumatica and temporal arteritis in United Kingdom, 1998–2001 L. Smeeth, C. Cook, A. Hall // Ann. Rheum. Dis. – 2006. – Vol. 65. – Р. 1093–1098.

[36] Spiera, R.F. Inflammatory diseases in older adults: polymyalgia rheumatica / R.F. Spiera, H. Spiera // Geriatrics. – 2004. – Vol. 59. – Р. 39–43.

[37] Swannell, A.J. Polymyalgia rheumatica and temporal arteritis: diagnosis and management / A.J. Swannell // BMJ. – 1997. – Vol. 314. – P. 1329–1332.

[38] Weyand, C.M. Arterial wall injury in giant cell arteritis / C.M. Weyand, J.J. Goronzy // Arth. Rheum. – 1999. – Vol. 42. – P. 844–853.

RIGHTS & PERMISSIONS

Eco-Vector